Related Experiment Videos
Interactions between helper T-cell epitopes of hepatitis C virus
Fenlu Zhu1, Meiying Yang, David D Eckels
1Department of Pediatrics, Medical College of Wisconsin, 8701 Watertown Plank Road, P.O. Box 26509, Milwaukee, WI 53226-0509, USA.
Vaccine
|April 28, 2005
Summary
Interactions between helper T-cell epitopes in hepatitis C virus (HCV) proteins influence immune responses. Suppressive Th2 epitopes can hinder Th1 responses, potentially contributing to chronic HCV infection and informing vaccine development.
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- Hepatitis C virus (HCV) infection is a global health concern.
- Helper T-cell responses play a critical role in viral clearance and chronic infection.
- The interplay between different T-cell epitopes within viral proteins is not fully understood.
Purpose of the Study:
- To investigate the synergistic effects of T-helper cell (Th) epitopes within HCV proteins.
- To determine how intramolecular interactions between Th1 and Th2 epitopes modulate immune responses.
- To explore the implications of these interactions for chronic HCV infection and vaccine strategies.
Main Methods:
- Construction of minigene and full-length HCV NS3 plasmids.
- Transfection of 293T cells and stimulation of patient-derived peripheral blood mononuclear cells (PBMCs).
- Measurement of cytokine production (IL-2, IFN-gamma) and PBMC proliferation.
Main Results:
- Evidence of synergistic interactions among helper T-cell epitopes within HCV proteins.
- Suppressive effects of Th2 epitopes on Th1 responses were observed, potentially contributing to chronic HCV.
- Synergistic interactions among Th1 epitopes led to increased IFN-gamma production, suggesting vaccine potential.
Conclusions:
- Helper T-cell epitope interactions significantly regulate immune responses to HCV.
- Imbalances in Th1/Th2 cytokine profiles or regulatory T-cells may underlie epitope-specific suppression.
- Understanding these epitope interactions offers a novel avenue for developing effective HCV vaccines.